Jyong Biotech Ltd. Ordinary Shares (MENS) — Financial Flexibility Index
Jyong Biotech Ltd. Ordinary Shares (MENS) has a Financial Flexibility Index of -0.02x as of December 2024. Free cash flow of $-913.00K (operating CF $-913.00K minus capex $0.00) represents 0% of total liabilities ($42.88 Million). Also explore MENS shareholders equity momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Jyong Biotech Ltd. Ordinary Shares Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Jyong Biotech Ltd. Ordinary Shares across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Jyong Biotech Ltd. Ordinary Shares.
Annual Financial Flexibility Index for Jyong Biotech Ltd. Ordinary Shares (2020–2025)
Year-by-year free cash flow to debt coverage for Jyong Biotech Ltd. Ordinary Shares. Explore how well can Jyong Biotech Ltd. Ordinary Shares service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.07x | $-3.04 Million | $-3.04 Million | $45.68 Million | ▲ +21.2% |
| 2024 | -0.08x | $-3.62 Million | $-3.62 Million | $42.88 Million | ▼ -37.5% |
| 2023 | -0.06x | $-2.60 Million | $-2.60 Million | $42.32 Million | ▲ +13.4% |
| 2022 | -0.07x | $-2.73 Million | $-2.97 Million | $38.38 Million | ▼ -25.9% |
| 2021 | -0.06x | $-1.85 Million | $-1.98 Million | $32.76 Million | ▼ -80.9% |
| 2020 | -0.03x | $-999.00K | $-1.09 Million | $32.05 Million | — |